Press release

Adents Prodigi Serialisation Solution Chosen by French Pharma Company to Ensure Compliance with EU Falsified Medicines Directive

Cloud Solution Enables Cristers to Easily Exchange Serialisation Data with Supply Chain Partners and Move Beyond Compliance to Improve Business Practices​

Adents had its Adents Prodigi cloud serialisation solution chosen by French pharmaceutical company Cristers to ensure compliance with the EU Falsified Medicines Directive (FMD) and provide beyond-compliance ROI. Jointly developed with Microsoft and powered by Azure, Adents Prodigi allows for secure data exchange and helps leverage the power of serialisation data to improve business practices.

Cristers markets generic and OTC products, and is a French Lab owned by a cooperative of pharmacists. Holding a marketing authorisation for more than 400 products, Cristers differentiates itself with clear and handy packaging to facilitate communication with patients.

While searching for a serialisation solution that would ensure compliance with the FMD, Cristers also sought a means of enabling easy exchange of serialisation data with its supply chain partners, including contract manufacturers and logistics providers. Additionally, Cristers wanted a solution that would aid in the onboarding of more than 30 European partners – including CMOs, vendors and third-party logistics providers – and facilitate connection with a diverse set of Levels 3 & 4 serialisation solutions.

Adents serialisation solutions are designed to help companies gain simplified speed to compliance with regulatory requirements.

The Adents Prodigi cloud-based Level 4 traceability solution met all of Cristers’ needs. The solution centrally manages regulatory requirements, provides an easy onboarding process to connect multiple trading partners, and facilitates significant business improvements by enabling companies to utilize the massive amounts of data generated during the serialisation and track & trace process.

“Adents Prodigi solution was the best native cloud Level 4 solution that offers us scalable and cost-efficient IT architecture in addition to a quick and easy partners on-boarding,” said Hervé Abou, Head Pharmacist of Cristers.

“Our pre-qualified software saves time during the validation phase, provides ultimate data security, and offers tremendous advanced analytics capabilities – enabling companies to move beyond compliance to improve business practices.” Added Christophe Devins, founder and CEO of Adents.


COVID-19: Adents' Business Continuity plan
The COVID-19 coronavirus epidemic has already affected thousands of people around the world and we expect the French government to announce stricter containment measures soon. Since Adents employees are mainly based in France and the United States, we take the health and economic risks linked to this epidemic very seriously.
Laboratoires Théa addresses European FMD and South Korea market regulation requirements with Adents Cloud serialization solution
Leading Ophtalmic Pharmaceuticals Company chose Adents Prodigi to connect with approximately 15 supply chain partners to stay compliant with current and future regulations.
Pharmascience Chooses Software from Adents to Ensure European FMD and US DSCSA Serialization Compliance Regulations
Pharmascience,the 4th largest manufacturer of over-the-counter and generic drugs in Canada, has chosen to partner with Adents, a leading provider of versatile and easily deployable serialization and track-and-trace software solutions, to assure compliance with the European Falsified Medicines Directive as well as the U.S. DSCSA serialization regulation.